Date stringdate 2012-01-01 00:00:00 2023-12-31 00:00:00 | Stock_symbol stringlengths 1 5 | Article_title stringlengths 1 255 | Article stringlengths 1 342k |
|---|---|---|---|
2022-07-18 00:00:00+00:00 | ABBV | $192 Price Target Makes AbbVie Stock a Notable Healthcare Pick | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Illinois-headquartered pharmaceutical firm AbbVie (NYSE:ABBV) never ceases to innovate in the healthcare market. A big-bank analyst just raised his price target on ABBV stock and AbbVie’s diversified product portfolio enhances the company’s value to both pa... |
2022-07-18 00:00:00+00:00 | ABBV | AbbVie (ABBV) Seeks EU Nod for Atogepant to Prevent Migraine | AbbVie, Inc. ABBV announced that it has submitted a marketing authorization application (“MAA”) to the European Medicines Agency (EMA), seeking approval for its CGRP receptor antagonist, atogepant, for prophylaxis treatment of migraine.
The MAA seeks approval for atogepant in adult patients who have at least four migra... |
2022-07-18 00:00:00+00:00 | ABBV | AbbVie: EMA's CHMP To Review Marketing Authorization Application For Migraine Drug Atogepant | (RTTNews) - AbbVie (ABBV) announced it has submitted a marketing authorization application or MAA to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.
The Committee for Medicinal Products for Human Use or CHMP will review the at... |
2022-07-17 00:00:00+00:00 | ABBV | Best Stocks for 2022: After Two Quarters, Who Holds The Lead? | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
At the end of each year, InvestorPlace invites its analysts and writers to take a stab at picking one stock they think will do better than the rest during the next year. Nine analysts chose stocks this year, and our readers chose their favorite in an open p... |
2022-07-17 00:00:00+00:00 | ABBV | Is InMode a Good Stock to Buy Now? | In 2021, it seemed as if medical technology stocks could do no wrong. Shares of cosmetic sculpting device manufacturer InMode (NASDAQ: INMD) more than doubled as enthusiasm for all things new and medically related reached a fever pitch.
Shares of InMode have tanked 72% since they hit an all-time high last November. Hig... |
2022-07-17 00:00:00+00:00 | ABBV | 3 Dividend Growth Stocks to Buy in July | What's better than stocks with a strong dividend? That's an easy question. The answer: Stocks with a strong dividend and share price that have excellent prospects to grow.
We asked three Motley Fool contributors to identify dividend growth stocks that are great picks to buy in July. Here's why they chose Abbott Laborat... |
2022-07-16 00:00:00+00:00 | ABBV | Want to Get Richer? 5 Best Stocks to Buy Now and Hold Forever | Healthcare is a massive industry; worldwide healthcare spending exceeded $8 trillion yearly in 2020 and 2021. Such an essential and lucrative field is fertile ground for great stocks.
You don't need to swing for a home run; hitting consistent base hits can get the job done. In other words, building wealth can be as eas... |
2022-07-15 00:00:00+00:00 | ABBV | This Stock Is Down By 13% This Year: Here's Why It's a Buy | It's been a mixed year for pharma giant Pfizer (NYSE: PFE). While the company's coronavirus-related portfolio continues to hit it out of the park, its shares have dropped by 13% since the beginning of the year. True, that's better than the performance of the S&P 500, but Pfizer is severely lagging similarly sized pharm... |
2022-07-15 00:00:00+00:00 | ABBV | Zacks Investment Ideas feature highlights: Dollar Tree, AbbVie and Sysco | For Immediate Release
Chicago, IL – July 15, 2022 – Today, Zacks Investment Ideas feature highlights Dollar Tree, Inc. DLTR, AbbVie ABBV and Sysco Corp. SYY.
3 Recession-Proof Stocks Up 10% in 2022 to Buy Right Now
Inflation showed no signs of cooling in June, with prices up 9.1% from a year ago to top estimates. Costs... |
2022-07-14 00:00:00+00:00 | ABBV | 3 Recession-Proof Stocks Up 10% in 2022 to Buy Right Now | Inflation showed no signs of cooling in June, with prices up 9.1% from a year ago to top estimates. Costs were up nearly across the board and are essentially washing away Americans’ wage gains. U.S. consumers are already feeling historically beaten down as they watch gas prices and grocery bills surge, and their sentim... |
2022-07-14 00:00:00+00:00 | ABBV | Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar? | Designed to provide broad exposure to the Large Cap Value segment of the US equity market, the First Trust Morningstar Dividend Leaders ETF (FDL) is a passively managed exchange traded fund launched on 03/09/2006.
The fund is sponsored by First Trust Advisors. It has amassed assets over $2.90 billion, making it one of ... |
2022-07-14 00:00:00+00:00 | ABBV | 3 Inflation-Resistant Stocks You Can Buy Right Now | The last time inflation was this high, the IBM personal computer was less than one year old, and Dallas and The Jeffersons ranked among the most watched TV shows.
While the stock market was down back in early 1982, there were still some businesses that handled inflation pretty well. The same is true today. Here are thr... |
2022-07-14 00:00:00+00:00 | ABBV | 2 Top Biotech Stocks Defying the Bear Market | Uncertainty over elevated inflation, future interest rate hikes, and a potential recession has weighed heavily on financial markets in 2022. In fact, the S&P 500 index has dipped 19% year to date.
But some sectors have fared far better to this point -- even as the markets have plunged. Since prescription drugs are need... |
2022-07-14 00:00:00+00:00 | ABBV | Here's How You Can Earn 10% of Your Investment Back in Dividends | Do you want to collect 10% of your investment back in dividends? There are stocks that yield that much right now, but there's often a significant risk with seeking out those types of investments. Generally, stocks with such high yields either have unsustainable payout ratios or their shares have been crashing heavily, ... |
2022-07-13 00:00:00+00:00 | ABBV | Noteworthy Wednesday Option Activity: ABBV, C, QCOM | Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in AbbVie Inc (Symbol: ABBV), where a total volume of 32,846 contracts has been traded thus far today, a contract volume which is representative of approximately 3.3 million underlying shares (given that every ... |
2022-07-13 00:00:00+00:00 | ABBV | See Which Of The Latest 13F Filers Holds AbbVie | At Holdings Channel, we have reviewed the latest batch of the 20 most recent 13F filings for the 06/30/2022 reporting period, and noticed that AbbVie Inc (Symbol: ABBV) was held by 13 of these funds. When hedge fund managers appear to be thinking alike, we find it is a good idea to take a closer look.
Before we proceed... |
2022-07-13 00:00:00+00:00 | ABBV | Better Dividend Stock: AbbVie or Johnson & Johnson? | The pharmaceutical industry is chock-full of companies that offer attractive dividends. AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) especially stand out. They're two of the largest drugmakers in the world with a long lineup of successful products.
But which is the better dividend stock? Here's how AbbVie and ... |
2022-07-12 00:00:00+00:00 | ABBV | Ex-Dividend Reminder: Cracker Barrel Old Country Store, DTE Energy and AbbVie | Looking at the universe of stocks we cover at Dividend Channel, on 7/14/22, Cracker Barrel Old Country Store Inc (Symbol: CBRL), DTE Energy Co (Symbol: DTP), and AbbVie Inc (Symbol: ABBV) will all trade ex-dividend for their respective upcoming dividends. Cracker Barrel Old Country Store Inc will pay its quarterly divi... |
2022-07-12 00:00:00+00:00 | ABBV | San Francisco reaches $54 million opioid settlement with Teva and Allergan | By Dietrich Knauth
July 12 (Reuters) - Teva Pharmaceutical Industries Inc TEVA.TA and AbbVie's ABBV.N Allergan business unit reached a $58 million opioid settlement with the city of San Francisco over claims that they fueled an opioid epidemic in the city, San Francisco City Attorney David Chiu announced.
Under the dea... |
2022-07-12 00:00:00+00:00 | ABBV | What's Happening With Merck Stock? | Merck stock (NYSE: MRK) has seen a 21% rise YTD, significantly outperforming its peers and the broader markets, with Johnson & Johnson stock up 4%, Pfizer stock down 6%, AbbVie stock up 12%, and the S&P500 index down 19%. There are a couple of factors aiding Merck’s stock growth. Firstly, the company’s Q1 performance w... |
2022-07-11 00:00:00+00:00 | ABBV | Notable ETF Inflow Detected - IVW, LLY, TMO, ABBV | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Growth ETF (Symbol: IVW) where we have detected an approximate $158.5 million dollar inflow -- that's a 0.5% increase week over week in outstanding units (from 463,550,000 to... |
2022-07-11 00:00:00+00:00 | ABBV | Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? | AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this drugmaker have returned +6.7%, compared to the Zacks S&P 500 composite's -5.1% change. Dur... |
2022-07-10 00:00:00+00:00 | ABBV | What's Driving AbbVie Stock Higher? | AbbVie stock (NYSE: ABBV) has seen a 14% rise YTD, marking a significant outperformance compared to some of its peers and the broader markets, with Johnson & Johnson stock rising 4%, Pfizer stock down 9%, and the S&P 500 index falling 20. Looking at the longer term, ABBV stock is up a solid 74% from levels seen in late... |
2022-07-10 00:00:00+00:00 | ABBV | How to Earn $10,000 a Year in Passive Retirement Income | Most people would probably agree that it's pretty sweet to see cash trickle into your account every quarter, especially if you didn't need to sell your labor to make it happen. As it turns out, generating passive income in retirement is a lot easier than it sounds, assuming you invest in the right high-quality dividend... |
2022-07-10 00:00:00+00:00 | ABBV | 3 Unstoppable Dividend Stocks to Buy and Never Sell | Unfortunately, "set and forget" isn't a strategy you can use with many stocks. Too many things can change over the years that can make a once-attractive stock an albatross on your portfolio.
There are exceptions, though. Some of them even offer solid dividends that boost your total returns significantly over time. Here... |
2022-07-10 00:00:00+00:00 | ABBV | 2 Surefire Dividend Stocks I'd Buy Now and Hold for at Least a Decade | It's hard to watch the value of your portfolio decline in a bear market. The pain is so acute right now that dividend-paying stocks tied to businesses with reliable cash flows have a hard time finding buyers at sensible prices.
Times like these are when the world's most successful investors do the most shopping. The ma... |
2022-07-09 00:00:00+00:00 | ABBV | This Company Could Ease the Pain in a Bear Market | Biotechnology company Vertex Pharmaceuticals (NASDAQ: VRTX) carved a name for itself in cystic fibrosis but has been slow to diversify into other diseases. That finally looks about to change as the company is on the verge of entering several new markets and dramatically expanding its total addressable patient populatio... |
2022-07-08 00:00:00+00:00 | ABBV | Chinook (KDNY) Stock Rallies 24.2% in 3 Months: Here's Why | Shares of Chinook Therapeutics KDNY have risen 24.2% in the past three months against the industry’s 5% decline.
Image Source: Zacks Investment Research
Berkley, CA-based Chinook is focused on developing precision medicines, targeting kidney diseases. With no marketable drugs in its portfolio, the company is entirely ... |
2022-07-08 00:00:00+00:00 | ABBV | Want to Beat the Bear Market? Try These 2 Stocks | The bear market has sent plenty of great companies into the doldrums. Most of us know that just by looking at our portfolios. And that's OK. We're in this for the long term. Once economic pressures ease, our favorite companies have a great chance of rebounding -- and gaining over time.
Meanwhile, it's always a good ide... |
2022-07-07 00:00:00+00:00 | ABBV | Health Care Sector Update for 07/07/2022: CTMX,ABBV,SRNE,KALV | Health care stocks still were narrowly higher this afternoon, with the NYSE Health Care Index rising 0.2% and the SPDR Health Care Select Sector ETF (XLV) up 0.3%.
The Nasdaq Biotechnology index was climbing 1.9% in recent trade.
In company news, CytomX Therapeutics (CTMX) dropped nearly 40% to a record low of $1.19 af... |
2022-07-07 00:00:00+00:00 | ABBV | Senate Finance report says AbbVie shifted profit overseas to cut taxes | By Michael Erman
July 7 (Reuters) - Drugmaker AbbVie Inc ABBV.O generates most of its sales in the United States, while shifting most of its profits overseas in order to avoid U.S. taxes, an interim report from the Senate Finance Committee said on Thursday.
According to the Democratic staff report, more than 75% of Ill... |
2022-07-07 00:00:00+00:00 | ABBV | Health Care Sector Update for 07/07/2022: KALV, SRNE, ABBV | Health care stocks were narrowly higher this afternoon, with the NYSE Health Care Index rising 0.2% and the SPDR Health Care Select Sector ETF (XLV) up 0.1%.
The Nasdaq Biotechnology index, however, was climbing 2.4% in recent trade.
In company news, KalVista Pharmaceuticals (KALV) rose over 12% after the early-stage d... |
2022-07-07 00:00:00+00:00 | ABBV | Best Stocks for 2022: AbbVie Is a Recession-Resistant Dividend King | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Editor’s note: This column is part of InvestorPlace.com’s Best Stocks for 2022 contest. Bob Ciura’s pick for the contest is AbbVie (NYSE:ABBV) stock.
The stock market recently entered bear market territory. Although the S&P 500 index has regained some groun... |
2022-07-06 00:00:00+00:00 | ABBV | These 5 Top Stocks Are Set to Outperform in a Recession | The Federal Reserve is grappling with elevated inflation by taking a hawkish stance and raising interest rates. The threat of a recession is real, and many consider it inevitable. This is the bad news. The good news is that some stocks perform well no matter what, others perform better historically during economic diff... |
2022-07-05 00:00:00+00:00 | ABBV | AbbVie (ABBV) Gains But Lags Market: What You Should Know | In the latest trading session, AbbVie (ABBV) closed at $153.93, marking a +0.08% move from the previous day. The stock lagged the S&P 500's daily gain of 0.16%. At the same time, the Dow lost 0.42%, and the tech-heavy Nasdaq gained 0.49%.
Coming into today, shares of the drugmaker had gained 4.96% in the past month. In... |
2022-07-05 00:00:00+00:00 | ABBV | Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now? | Making its debut on 05/08/2007, smart beta exchange traded fund First Trust Health Care AlphaDEX ETF (FXH) provides investors broad exposure to the Health Care ETFs category of the market.
What Are Smart Beta ETFs?
The ETF industry has traditionally been dominated by products based on market capitalization weighted ind... |
2022-07-05 00:00:00+00:00 | ABBV | This Blockbuster Drug from AbbVie Is Closer to Another Major Indication | The European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) recently adopted a positive opinion that recommended the approval of AbbVie's (NYSE: ABBV) Rinvoq for what would be its fifth indication in that market. This would be to treat patients with moderate-to-severe ulcerative colitis who had... |
2022-07-03 00:00:00+00:00 | ABBV | 2 First-Rate ETFs for Stock Dividends | Exchange-traded funds (ETFs) designed to generate dividend income have become more popular in this market cycle as investors seek investments that can balance out the losses in their portfolios. Dividend-focused ETFs can provide income if you decide to take the distributions, but they can also boost the total return of... |
2022-07-02 00:00:00+00:00 | ABBV | 3 Stocks You Can Buy and Hold for Decades | Three little words can make you a lot of money over the long term: Buy and hold. However, the catch is that you must find the right stocks for those three words to work most effectively.
We asked three Motley Fool contributors which stocks you can buy and hold for decades. Here's why they picked AbbVie (NYSE: ABBV), Br... |
2022-07-01 00:00:00+00:00 | ABBV | Amgen's Beating the Market -- Here's Why It's a Buy Now | Amgen (NASDAQ: AMGN) is the world's largest biotechnology company by revenue, focusing on using living cells to create a robust product portfolio of biologic medicines to treat serious diseases in several areas -- among them, cardiovascular, oncology, and neuroscience. In 2022, the company's stock has returned over 9% ... |
2022-07-01 00:00:00+00:00 | ABBV | The 3 Best Dividend Aristocrat Stocks in the First Half of 2022: Are They Buys Now? | Dividend stocks aren't always known for generating sizzling gains. However, investors have flocked to some dividend payers this year as the overall market has tumbled.
Some of the biggest winners are among the elite group of S&P 500 members that have increased their dividends for at least 25 consecutive years. Here are... |
2022-06-30 00:00:00+00:00 | ABBV | SPLG, BRK.B, ABBV, BAC: ETF Inflow Alert | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Portfolio S&P 500 ETF (Symbol: SPLG) where we have detected an approximate $205.8 million dollar inflow -- that's a 1.6% increase week over week in outstanding units (from 281,900,000 t... |
2022-06-30 00:00:00+00:00 | ABBV | 2 of the Safest Stocks to Buy in a Recession | What's next for the U.S. economy? It's hard to even wager a guess. Soaring oil prices caused by Russia's invasion of Ukraine at the tail end of a global pandemic present an especially unpredictable economic environment.
In uncertain times like these, it helps to own stocks that you can rely on to produce strong cash fl... |
2022-06-29 00:00:00+00:00 | ABBV | The Best Stocks to Invest $5,000 in Right Now | It's nearly impossible to come up with a "best stock to invest in" list that everyone will agree on. That's partly because the stock market brings together people with different goals, investing styles, and income levels. However, beating the market is a pretty good goal.
Let's look at two stocks worth investing $5,000... |
2022-06-29 00:00:00+00:00 | ABBV | Is Most-Watched Stock AbbVie Inc. (ABBV) Worth Betting on Now? | AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Shares of this drugmaker have returned +3.5% over the past month versus the Zacks S&P 500 composite's -8% change. The Zacks La... |
2022-06-29 00:00:00+00:00 | ABBV | Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)? | Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the First Trust Health Care AlphaDEX ETF (FXH), a passively managed exchange traded fund launched on 05/08/2007.
Retail and institutional investors increasingly turn to passively managed ETFs because they offer low co... |
2022-06-28 00:00:00+00:00 | ABBV | 2 Buffett Stocks That Outperformed the S&P During the Great Recession | There are two things that Teva Pharmaceutical Industries (NYSE: TEVA) and Amazon (NASDAQ: AMZN) have in common. They've both been investments that Warren Buffett's Berkshire Hathaway held in its portfolio (Amazon is a current holding while Teva was recently sold) , and they both outperformed the S&P 500 during the Grea... |
2022-06-27 00:00:00+00:00 | ABBV | AbbVie: Europe's CHMP Recommends To Approve Upadacitinib To Treat Active Nr-axSpA Patients | (RTTNews) - AbbVie (ABBV) announced Monday that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP recommended the approval of upadacitinib (RINVOQ) for the treatment of adults with active non-radiographic axial spondyloarthritis or nr-axSpA.
The European Union decision is expected i... |
2022-06-27 00:00:00+00:00 | ABBV | AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication | AbbVie Inc. ABBV announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (“CHMP”) has rendered a positive opinion on, and recommended granting approval to its JAK inhibitor drug — Rinvoq (upadacitinib) — for yet another new indication.
The committee recommended approval of once-dai... |
2022-06-27 00:00:00+00:00 | ABBV | AbbVie (ABBV) Gains As Market Dips: What You Should Know | AbbVie (ABBV) closed at $153.14 in the latest trading session, marking a +0.53% move from the prior day. The stock outpaced the S&P 500's daily loss of 0.3%. Elsewhere, the Dow lost 0.2%, while the tech-heavy Nasdaq lost 0.1%.
Coming into today, shares of the drugmaker had gained 1.56% in the past month. In that same t... |
2022-06-27 00:00:00+00:00 | ABBV | Is AbbVie About To Get A New Blockbuster Drug? | Last month, AbbVie (NYSE: ABBV) submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for the compound ABBV-951 to treat motor fluctuations in patients with advanced Parkinson's disease.
The pharma company expects to make more submissions to other regulatory authorities in the months ahead for... |
2022-06-27 00:00:00+00:00 | ABBV | 5 Best Dividend Stocks to Buy Now | In this video, I will be talking about five dividend-paying companies that you might want to add to your portfolio. Dividend stocks can provide stability during rough times like today. Intel (NASDAQ: INTC) is currently the only one in my portfolio, but I might add more in these coming months.
For the full insights, do ... |
2022-06-26 00:00:00+00:00 | ABBV | 4 Top Dividend Stocks To Watch Amid Recession Concerns | Check Out These Dividend Stocks For Your Late June Watchlist
As the stock market appears to be attempting a recovery, there remains plenty of uncertainty. Thus, dividend stocks could be on the minds of investors. For one, companies that can pay dividends to their shareholders are often those with a track record of prof... |
2022-06-26 00:00:00+00:00 | ABBV | 3 Top Dividend Stocks for Generating Passive Income | You can work for money. But you can also have your money work for you. One great way to make passive income is to invest in dividend stocks.
We asked three Motley Fool contributors to identify top dividend stocks for generating passive income. Here's why they selected AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD)... |
2022-06-24 00:00:00+00:00 | ABBV | Daily Dividend Report: ABBV,EIX,DTE,BFS,BKSC | The board of directors of AbbVie today declared a quarterly cash dividend of $1.41 per share. The cash dividend is payable August 15, 2022, to stockholders of record at the close of business on July 15, 2022. Since the company's inception in 2013, AbbVie has increased its dividend by more than 250 percent. AbbVie is a ... |
2022-06-23 00:00:00+00:00 | ABBV | Got $1,000? Buy These 2 Ultra-High-Yield Dividend Stocks on the Dip | Sometimes a stock falls to levels so low, it almost doesn't matter what an investor's budget is -- they have to buy at least a few shares to take advantage of the situation. With the market's retreat lately, a great many stocks are at, or teasing, their recent low-water marks.
This presents some nearly irresistible opp... |
2022-06-22 00:00:00+00:00 | ABBV | Noteworthy Wednesday Option Activity: SPLK, C, ABBV | Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Splunk Inc (Symbol: SPLK), where a total volume of 10,501 contracts has been traded thus far today, a contract volume which is representative of approximately 1.1 million underlying shares (given that e... |
2022-06-22 00:00:00+00:00 | ABBV | What Stocks To Invest In Today? 3 Pharmaceutical Stocks To Watch | 3 Pharmaceutical Stocks For Your Watchlist Right Now
For investors wondering what are the best stocks to invest in today, pharmaceutical stocks would be an interesting play. On the whole, this part of the stock market is home to companies of varying sizes and specializations. The likes of which serve to aid people acro... |
2022-06-22 00:00:00+00:00 | ABBV | HDV, ABBV, PM, BMY: Large Inflows Detected at ETF | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core High Dividend ETF (Symbol: HDV) where we have detected an approximate $184.8 million dollar inflow -- that's a 1.5% increase week over week in outstanding units (from 124,600,00... |
2022-06-22 00:00:00+00:00 | ABBV | AbbVie (ABBV) Files Qulipta sNDA for Chronic Migraine Prevention | AbbVie ABBV submitted a supplemental new drug application (sNDA) with the FDA, seeking approval for the expanded use of its newly approved CGRP receptor antagonist, Qulipta (atogepant), for the prevention of chronic migraine.
Qulipta was approved for the preventive treatment of episodic migraine in adults in September ... |
2022-06-22 00:00:00+00:00 | ABBV | Better Buy: Dividend Stocks or Growth Stocks? | With the market moving to a risk-off environment, the question of whether to buy dividend stocks or growth stocks is top of mind for investors.
The answer lies in understanding your own personal investor profile. While some may argue dividend-paying stocks are a safer place to put your money as multiples condense, many... |
2022-06-22 00:00:00+00:00 | ABBV | AbbVie: Health Canada Approves Label Extension For MAVIRET To Include Use In Paediatric Patients | (RTTNews) - AbbVie (ABBV) announced Health Canada has approved a change in the marketing authorization for MAVIRET to include its use for the treatment in paediatric patients 3 to 12 years old, weighing at least 12kg to less than 45kg. It is now approved as an 8-week, pan-genotypic treatment for treatment-naïve, chroni... |
2022-06-21 00:00:00+00:00 | ABBV | AbbVie Files SNDA For Atogepant For Label Expansion | (RTTNews) - AbbVie (ABBV) announced it has submitted a supplemental New Drug Application for atogepant to the FDA to support the preventive treatment of chronic migraine in adults. The company noted that the submission is based on pivotal phase 3 PROGRESS chronic migraine study evaluating atogepant in adult patients th... |
2022-06-20 00:00:00+00:00 | ABBV | AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know | AbbVie (ABBV) closed the most recent trading day at $138.28, moving -0.63% from the previous trading session. This change lagged the S&P 500's daily gain of 0.22%. Elsewhere, the Dow lost 0.13%, while the tech-heavy Nasdaq added 0.22%.
Coming into today, shares of the drugmaker had lost 8.43% in the past month. In that... |
2022-06-20 00:00:00+00:00 | ABBV | AbbVie's (ABBV) Skyrizi Gets FDA Nod for Crohn's Disease | AbbVie ABBV announced that the FDA has approved its drug Skyrizi (risankizumab) for its third indication, moderately to severely active Crohn’s disease (“CD”).
Skyrizi can now be used as a 600mg intravenous induction at week 0, week 4, and week 8, followed by 360 mg self-administered by subcutaneous injection with an ... |
2022-06-20 00:00:00+00:00 | ABBV | Finally, a Reasonable Price For This Healthcare Blue Chip | The investor community holds high regard for healthcare conglomerate Abbott Laboratories (NYSE: ABT). Shares rarely come cheap, typically commanding a higher valuation than the S&P 500.
However today Abbott Labs is trading nearly 30% below its high, thanks to recent volatility on Wall Street.
The stock has crushed the ... |
2022-06-19 00:00:00+00:00 | ABBV | Want to Retire Early? These 5 Ultra-High-Yield Dividend Stocks Can Help | Retirement doesn't necessarily have to wait until you are in your 60s; working becomes optional as soon as your passive income covers your living expenses.
Buying dividend stocks, which make so much money that they give a chunk of their profits on a regular basis to shareholders, can eventually build a waterfall of cas... |
2022-06-18 00:00:00+00:00 | ABBV | 3 Dividend Stocks to Double Up on Right Now | With the market tumbling and dividend yields rising, now is a great time to be loading up on great, cash-yielding stocks. If you can find the right businesses to invest in today, you stand to gain a considerable amount on your purchase in the long run, when the current turbulence is just a distant memory.
In this vein,... |
2022-06-17 00:00:00+00:00 | ABBV | First Week of February 2023 Options Trading For AbbVie (ABBV) | Investors in AbbVie Inc (Symbol: ABBV) saw new options begin trading this week, for the February 2023 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 245 days until expiration the newly trading contracts represent a potential opportunity for selle... |
2022-06-17 00:00:00+00:00 | ABBV | 5 Stocks Warren Buffett Has Aggressively Sold Since 2022 Began | When Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street and investors wisely pay close attention. That's because the Oracle of Omaha has delivered an aggregate return on the company's Class A shares (BRK.A) of 3,641,613% during his 57 years at the helm (through Dec. 31, 2021).
While r... |
2022-06-16 00:00:00+00:00 | ABBV | AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know | AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Shares of this drugmaker have returned -9.4% over the past month versus the Zacks S&P 500 composite's -5.6% change. The Zacks Large C... |
2022-06-15 00:00:00+00:00 | ABBV | Is There A Better Pick Over Merck Stock In Animal Health Space? | We think that Zoetis stock (NYSE: ZTS) currently is a better pick compared to its peer Merck stock (NYSE: MRK), despite Zoetis being the more expensive of the two, trading at 9x trailing revenues, compared to just 4x for Merck. This valuation gap can be attributed to Zoetis’ better profitability.
If we look at stock re... |
2022-06-14 00:00:00+00:00 | ABBV | AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know | AbbVie (ABBV) closed the most recent trading day at $137.62, moving -1.29% from the previous trading session. This move lagged the S&P 500's daily loss of 0.38%. At the same time, the Dow lost 0.5%, and the tech-heavy Nasdaq lost 0.46%.
Coming into today, shares of the drugmaker had lost 10.32% in the past month. In th... |
2022-06-14 00:00:00+00:00 | ABBV | Notable ETF Inflow Detected - HDV, ABBV, PM, BMY | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core High Dividend ETF (Symbol: HDV) where we have detected an approximate $349.3 million dollar inflow -- that's a 2.8% increase week over week in outstanding units (from 121,150,00... |
2022-06-14 00:00:00+00:00 | ABBV | Lilly (LLY), Incyte's Olumiant Gets FDA Nod for Alopecia Areata | Eli Lilly LLY and partner Incyte INCY announced that the FDA has granted approval to their oral JAK inhibitor, Olumiant (baricitinib) for treating adults with severe alopecia areata (“AA”). This autoimmune disorder results in non-scarring hair loss.
Until now there were no FDA-approved systemic treatments for AA. Syste... |
2022-06-14 00:00:00+00:00 | ABBV | The Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, TotalEnergies, Linde and AT&T | For Immediate Release
Chicago, IL – June 14, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Berkshire Hathaway Inc. (BRK.... |
2022-06-13 00:00:00+00:00 | ABBV | Consistent Clinical Results Indicate Upside for AbbVie Stock | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Illinois-headquartered AbbVie (NYSE:ABBV) is famous among pharmaceutical businesses for its diversified portfolio of medical treatments and solutions. ABBV stock is an outstanding deal at the current share price as AbbVie continues to develop industry-leadi... |
2022-06-13 00:00:00+00:00 | ABBV | Should You Invest in the VanEck Pharmaceutical ETF (PPH)? | If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on 12/20/2011.
Passively managed ETFs are becoming increasingly popular with institutional as well as retail investo... |
2022-06-13 00:00:00+00:00 | ABBV | Top Analyst Reports for Berkshire Hathaway, AbbVie & TotalEnergies | Monday, June 13, 2022
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), AbbVie Inc. (ABBV), and TotalEnergies SE (TTE). These research reports have been hand-picked from the ... |
2022-06-13 00:00:00+00:00 | ABBV | AbbVie Enters Oversold Territory | The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. AbbVie Inc (Symbol: ABBV) presently has an... |
2022-06-12 00:00:00+00:00 | ABBV | Top Biotech Stocks To Invest In Today? 3 To Watch This Week | Are These The Best Biotech Stocks To Buy Right Now?
Even with inflation data coming in hotter-than-expected, investors would likely be looking for the most active stocks today. Should this be the case, biotech stocks would make for a viable option in the stock market now. For the most part, this would be the case as th... |
2022-06-11 00:00:00+00:00 | ABBV | AbbVie : Phase 2 Trial Of Epcoritamab Shows Clinically Meaningful Efficacy In Large B-cell Lymphoma | (RTTNews) - AbbVie (ABBV) said results from phase 2 trial of investigational epcoritamab (DuoBody-CD3xCD20) in patients with Relapsed/Refractory Large B-cell Lymphoma showed clinically meaningful efficacy.
In the study, the nvestigational subcutaneous bispecific antibody epcoritamab demonstrated efficacy with durable r... |
2022-06-11 00:00:00+00:00 | ABBV | 2 Best Biotech Stocks to Buy Right Now | The launch of quality healthcare services and products over the past several decades has had an overwhelmingly positive impact on society. That's because these goods and services can prevent or treat many chronic medical conditions, which has resulted in an improved quality of life for many patients.
Here are two estab... |
2022-06-10 00:00:00+00:00 | ABBV | AbbVie : Data Shows Venclyxto/Venclexta Combination Sustained PFS In Chronic Lymphocytic Leukemia | (RTTNews) - AbbVie (ABBV) announced five-year follow-up results from the phase 3 CLL14 trial, finding that more than 60 percent of patients with previously untreated chronic lymphocytic leukemia or CLL who had received one-year fixed-duration combination treatment of Venclyxto/Venclexta (venetoclax) plus obinutuzumab (... |
2022-06-10 00:00:00+00:00 | ABBV | EXCLUSIVE-CVC explores $2 billion sale of software firm VelocityEHS -sources | By Emma-Victoria Farr and Krystal Hu
June 10 (Reuters) - Private equity firm CVC Capital Partners is exploring a sale of VelocityEHS for as much as $2 billion, seeking to capitalize on a boom in demand for compliance software in the corporate world, three people familiar with the matter said.
CVC is working with U.S. i... |
2022-06-10 00:00:00+00:00 | ABBV | 3 Dividend Stocks to Buy Now for 20 Years of Income Growth | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Dividends can be an important source of income for investors. Consider that Warren Buffett earns more than $4 billion a year in dividend payments from his vast stock holdings, including more than $500 million from his position in Coca-Cola (NYSE:KO) alone, ... |
2022-06-09 00:00:00+00:00 | ABBV | ABBV July 29th Options Begin Trading | Investors in AbbVie Inc (Symbol: ABBV) saw new options become available today, for the July 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABBV options chain for the new July 29th contracts and identified one put and one call contract of particular interest.
The put contrac... |
2022-06-08 00:00:00+00:00 | ABBV | Could AbbVie Stock Help You Retire a Millionaire? | Building wealth for retirement is a lot easier when you own shares of companies that can keep growing for years and years without getting topped by rivals or otherwise swept away by the changing winds of the market. For example, mature businesses like AbbVie (NYSE: ABBV) are often especially favorable for retirement sa... |
2022-06-07 00:00:00+00:00 | ABBV | What Stocks To Buy Today? 3 Biotech Stocks To Know | 3 Top Biotech Stocks For Your June 2022 Watchlist
For investors looking for the most active stocks in the stock market now, biotech stocks could be a go-to. After all, companies across the industry are constantly providing key updates on their latest developmental pipeline advances. Aside from this, there would also be... |
2022-06-07 00:00:00+00:00 | ABBV | Warren Buffett Just Sold This Popular Stock -- Should You? | When it comes to success with investing, Warren Buffett is hard to one-up, to say the least. But even if you can't outperform him, you just might be able to get (approximately) similar returns by copying his trades or at least dodge some problems by selling when he does.
On that note, in the first quarter of this year,... |
2022-06-07 00:00:00+00:00 | ABBV | Surprising Analyst 12-Month Target For SDY | Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR S&P Dividend ETF (Symbol: ... |
2022-06-06 00:00:00+00:00 | ABBV | AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know | AbbVie (ABBV) closed the most recent trading day at $146.53, moving -0.43% from the previous trading session. This change lagged the S&P 500's daily gain of 0.31%. Meanwhile, the Dow gained 0.05%, and the Nasdaq, a tech-heavy index, added 0.14%.
Prior to today's trading, shares of the drugmaker had lost 3.7% over the p... |
2022-06-06 00:00:00+00:00 | ABBV | The Health Care Select Sector SPDR Fund Experiences Big Inflow | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $908.7 million dollar inflow -- that's a 2.4% increase week over week in outstanding units (from 2... |
2022-06-05 00:00:00+00:00 | ABBV | 3 Great Dividend Stocks to Buy in June | Guess which stocks tend to perform better than most during market downturns? If your answer is solid dividend stocks, you're exactly right.
We asked three Motley Fool contributors to pick great dividend stocks to buy in June. Here's why they chose AbbVie (NYSE: ABBV), Novartis (NYSE: NVS), and Viatris (NASDAQ: VTRS).
I... |
2022-06-05 00:00:00+00:00 | ABBV | Can the Best-Selling Drugs of 2021 Repeat Their Performance? | Investors looking for stocks that can put up big gains know that pharmaceutical sales can make it happen. Two out of three of the world's top-selling drugs weren't even available in 2020.
Last year, in the U.S. alone, prescription drug sales reached $577 billion, and that was 7.7% more than a year earlier. A substantia... |
2022-06-04 00:00:00+00:00 | ABBV | 2 Top Dividend Kings to Buy for the Long Haul | Trusted dividend stocks tend to both perform well compared to the broader market and consistently raise their dividends, regardless of what's going on in the world.
The most respected dividend stocks are those that have increased their payouts for at least 50 consecutive years. These stocks are called Dividend Kings. T... |
2022-06-03 00:00:00+00:00 | ABBV | Best Health Care Stocks To Invest In Today? 3 In Focus | 3 Health Care Stocks For Your June 2022 Watchlist
With all the back-and-forth in the stock market recently, investors may be looking for more defensive stocks to jump on. Should that be the case, health care stocks would be among the key groups to consider. After all, the industry produces a vast array of life-improvin... |
2022-06-03 00:00:00+00:00 | ABBV | AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It | AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Over the past month, shares of this drugmaker have returned -3.6%, compared to the Zacks S&P 500 composite's +0.... |
2022-06-03 00:00:00+00:00 | ABBV | J&J, AbbVie cancer drug significantly slows progression of rare lymphoma -study | By Michael Erman
June 3 (Reuters) - Johnson & Johnson JNJ.N and AbbVie's ABBV.N big-selling leukemia drug Imbruvica in combination with standard treatment kept a rare type of non-Hodgkin lymphoma in check for more than two years longer than the standard regimen alone in older patients, according to data presented on Fr... |
2022-06-02 00:00:00+00:00 | ABBV | Bristol Myers, J&J drugs reduce COVID death rates in NIH study | Adds background and details
June 2 (Reuters) - A late-stage study of two rheumatoid arthritis drugs from Bristol Myers Squibb BMY.N and Johnson & Johnson JNJ.N showed a significant drop in deaths among hospitalized COVID patients, a U.S. health agency said on Thursday.
However, both the drugs failed to meet the main go... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.